Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18435068 | SOLANUM LYCOPERSICUM SEED OIL FREEZE-DRIED POWDER WITH WHITENING EFFICACY, COMPOSITION, AND PREPARATION METHOD AND APPLICATION THEREOF | February 2024 | June 2025 | Allow | 16 | 2 | 1 | No | No |
| 18432437 | POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION | February 2024 | May 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18414445 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | January 2024 | March 2024 | Allow | 2 | 0 | 0 | No | No |
| 18414442 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | January 2024 | May 2024 | Allow | 4 | 0 | 1 | No | No |
| 18382887 | 9-(5-BROMO-2-HYDROXYPHENYL)-10-[3-(DIMETHYLAMINO)PROPYL]-3,4,6,7,9,10-HEXAHYDROACRIDINE-1,8(2H,5H)-DIONE AS AN ANTIMICROBIAL COMPOUND | October 2023 | March 2024 | Allow | 5 | 1 | 1 | No | No |
| 18465918 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | September 2023 | August 2024 | Abandon | 11 | 1 | 1 | No | No |
| 18332194 | TRANSDERMAL ADHESIVE COMPOSITION COMPRISING A POORLY SOLUBLE THERAPEUTIC AGENT | June 2023 | September 2024 | Abandon | 16 | 1 | 0 | No | No |
| 18332434 | Composition Containing a Cellulose Derived Capsule With a Sunscreen | June 2023 | May 2025 | Abandon | 23 | 2 | 0 | No | No |
| 18103998 | UNIVERSAL MINERAL BASED SUNSCREEN AND RELATED METHODS OF MANUFACTURE | January 2023 | July 2024 | Allow | 18 | 2 | 1 | No | No |
| 18076951 | Method And Device for Treating Venous Insufficiency And Varicose Veins | December 2022 | June 2024 | Allow | 19 | 1 | 1 | No | No |
| 17925849 | A HIGH UV PROTECTION CLEANSING COMPOSITION | November 2022 | November 2024 | Abandon | 24 | 3 | 1 | No | No |
| 18054185 | SOLID DOSAGE FORMS OF TAFAMIDIS | November 2022 | August 2023 | Abandon | 9 | 0 | 1 | No | No |
| 18053193 | ORAL FORMULATIONS OF BIPOLAR TRANS CAROTENOIDS | November 2022 | January 2025 | Abandon | 27 | 0 | 1 | No | No |
| 18053322 | Compositions Containing a Capsule with an Agent | November 2022 | May 2024 | Abandon | 19 | 1 | 1 | No | No |
| 17995174 | Method for manufacturing spicule coated with diamond and ingredients effective for skin improvement, and diamond spicule cosmetic composition including the same | September 2022 | May 2025 | Allow | 31 | 1 | 1 | No | No |
| 17932469 | Topical Delivery System Containing Cellulose Nanofibers | September 2022 | August 2024 | Abandon | 23 | 2 | 0 | Yes | No |
| 17863754 | DOSAGE FORMS OF TAFAMIDIS AND ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | July 2022 | October 2023 | Abandon | 15 | 1 | 1 | No | No |
| 17844904 | LIGHT AESTHETIC SUNSCREEN COMPOSITIONS | June 2022 | August 2024 | Abandon | 26 | 2 | 0 | No | No |
| 17843440 | COSMETIC COMPOSITION HAVING INCREASED SKIN CONTACT AND MAKEUP PERSISTENCE AND METHOD OF MANUFACTURING SAME | June 2022 | October 2023 | Allow | 16 | 2 | 0 | No | No |
| 17743501 | TRIAZINE FORMULATIONS WITH A SECOND ACTIVE INGREDIENT AND SURFACTANT(S) | May 2022 | October 2023 | Allow | 17 | 1 | 0 | No | No |
| 17733344 | METHOD OF MANAGING DIFFERENT STAGES IN A WOMEN'S LIFE | April 2022 | September 2023 | Abandon | 16 | 2 | 1 | Yes | No |
| 17715369 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | April 2022 | April 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17633350 | EXTRACT OF MORINGA PEREGRINA SEED CAKE, METHOD FOR OBTAINING SAME AND USE THEREOF IN COSMETIC OR NUTRICOSMETIC COMPOSITIONS | February 2022 | February 2025 | Allow | 36 | 3 | 1 | No | No |
| 17627439 | METHOD FOR MICRO-ENCAPSULATION OF NATURAL INGREDIENTS BY MEANS OF CONTACTING WITH SUPERCRITICAL GAS | January 2022 | April 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17624149 | PRESSED POWDER COMPOSITION | December 2021 | May 2024 | Abandon | 28 | 2 | 1 | Yes | No |
| 17545206 | SKIN CARE COMPOSITIONS AND METHODS FOR REGULATING SEBUM PRODUCTION | December 2021 | September 2022 | Allow | 9 | 2 | 1 | Yes | No |
| 17539101 | SKIN BRIGHTENING COMPOSITION | November 2021 | November 2023 | Abandon | 23 | 1 | 0 | No | No |
| 17530003 | DOSAGE FORMS OF TAFAMIDIS AND ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | November 2021 | September 2022 | Allow | 10 | 1 | 1 | Yes | No |
| 17453964 | MEDICAL MOISTURIZING EYE PATCH AND PREPARATION METHOD THEREOF | November 2021 | January 2025 | Allow | 38 | 1 | 0 | No | No |
| 17494870 | TRIAZINE FORMULATIONS WITH A SECOND ACTIVE INGREDIENT AND SURFACTANT(S) | October 2021 | October 2023 | Allow | 24 | 1 | 0 | Yes | No |
| 17494866 | TRIAZINE FORMULATIONS WITH A SECOND ACTIVE INGREDIENT AND SURFACTANT(S) | October 2021 | October 2023 | Allow | 24 | 1 | 0 | Yes | No |
| 17441533 | IMPLANTABLE OCULAR DRUG DELIVERY DEVICES AND METHODS | September 2021 | June 2025 | Abandon | 45 | 0 | 1 | No | No |
| 17470971 | PETROLATUM-BASED DELIVERY SYSTEMS AND FOR ACTIVE INGREDIENTS | September 2021 | September 2024 | Abandon | 37 | 1 | 1 | No | No |
| 17468809 | PETROLATUM-BASED COMPOSITIONS AND METHODS OF TREATMENT FOR ONYCHOMYCOSIS | September 2021 | June 2025 | Allow | 45 | 2 | 1 | No | No |
| 17467406 | PETROLATUM-BASED PHMB COMPOSITIONS AND METHODS OF TREATMENT FOR ONYCHOMYCOSIS | September 2021 | May 2024 | Allow | 32 | 1 | 1 | No | No |
| 17434390 | HYDROGEL COMPOSITIONS AND METHODS FOR TREATMENT OF MALIGNANCIES | August 2021 | April 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17394332 | Compositions and Methods for Preparation of Solidified Oil for Treating Hair and Scalp | August 2021 | May 2024 | Abandon | 34 | 2 | 1 | Yes | No |
| 17427369 | NON-THERAPEUTIC ORAL USE OF A COMPOSITION FOR WHITENING AND/OR LIGHTENING THE SKIN COMPRISING CYSTINE AND GLUTATHIONE IN A CYSTINE-GLUTATHIONE RATIO RANGING FROM 1.5 TO 4 | July 2021 | February 2024 | Allow | 31 | 4 | 1 | No | No |
| 17419524 | MICROPARTICLES OF CELLULOSE NANOCRYSTALS WITH PIGMENT NANOPARTICLES BOUND THERETO AND METHOD OF PRODUCTION THEREOF | June 2021 | May 2024 | Allow | 35 | 3 | 1 | No | No |
| 17356136 | ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS | June 2021 | May 2025 | Abandon | 47 | 3 | 1 | No | No |
| 17344077 | Hair Or Skin Treatment Composition And Methods Of Preparation And Use | June 2021 | April 2024 | Allow | 34 | 2 | 1 | No | No |
| 17327972 | PERSONAL CARE COMPOSITIONS SUBSTANTIALLY FREE OF SULFATED SURFACTANTS AND CONTAINING A GEL NETWORK | May 2021 | September 2024 | Allow | 40 | 4 | 0 | No | No |
| 17326485 | SILVER ION BACTERIOSTATIC HAND SANITIZER AND PREPARATION METHOD AND APPLICATION THEREOF | May 2021 | September 2021 | Allow | 4 | 0 | 1 | Yes | No |
| 17291544 | COSMETIC COMPOSITION | May 2021 | December 2022 | Abandon | 20 | 3 | 0 | Yes | No |
| 17222061 | PETROLATUM-BASED DELIVERY SYSTEMS AND FOR ACTIVE INGREDIENTS | April 2021 | May 2024 | Allow | 37 | 2 | 0 | No | No |
| 17278922 | INSECTICIDAL COMPOUNDS | March 2021 | September 2024 | Abandon | 41 | 0 | 1 | No | No |
| 17190754 | MANUFACTURING PROCESS FOR 2-PHASE SPRAY CONDITIONER | March 2021 | November 2023 | Allow | 32 | 1 | 1 | No | No |
| 17271147 | THERAPEUTIC COMBINATIONS OF CANNABINOIDS WITH CURCUMIN | February 2021 | September 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17161446 | POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION | January 2021 | February 2024 | Abandon | 36 | 1 | 1 | No | No |
| 17258357 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID-RELATED DISORDERS | January 2021 | May 2025 | Allow | 52 | 1 | 1 | No | No |
| 17258262 | A COMPOSITION CONTAINING CASHEW LEAF EXTRACT AND PRODUCTION METHOD THEREOF | January 2021 | February 2024 | Abandon | 37 | 0 | 1 | No | No |
| 17136353 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | December 2020 | May 2025 | Abandon | 53 | 4 | 1 | No | Yes |
| 17135646 | PETROLATUM-BASED COMPOSITIONS COMPRISING CATIONIC BIOCIDES | December 2020 | May 2024 | Allow | 41 | 1 | 1 | No | No |
| 17255574 | A METHOD OF PROVIDING CUSTOMIZED COLOR SHADE SUNSCREEN PRODUCTS | December 2020 | April 2025 | Abandon | 51 | 3 | 1 | Yes | No |
| 17127365 | Sunscreen and Bug Repellant Formula | December 2020 | August 2023 | Abandon | 32 | 1 | 1 | No | No |
| 17123274 | CLEANSING CREAM FORMULATION | December 2020 | September 2022 | Allow | 21 | 1 | 0 | No | No |
| 17116966 | Composition For Providing High Lift And Color Deposit | December 2020 | June 2023 | Abandon | 31 | 3 | 1 | No | No |
| 17114769 | Temporary Hair Coloring | December 2020 | December 2023 | Abandon | 36 | 2 | 1 | No | No |
| 16972530 | COSMETIC COMPOSITION FOR SKIN WHITENING | December 2020 | July 2023 | Abandon | 32 | 1 | 1 | No | No |
| 17108361 | WATER-IN-OIL EMULSION COMPOSITION | December 2020 | August 2022 | Abandon | 20 | 1 | 0 | No | No |
| 17104350 | COSMETIC COMPOSITION HAVING INCREASED SKIN CONTACT AND MAKEUP PERSISTENCE AND METHOD OF MANUFACTURING SAME | November 2020 | October 2022 | Abandon | 23 | 1 | 0 | No | No |
| 17057320 | SKIN LIGHTENING AGENT | November 2020 | September 2024 | Allow | 46 | 2 | 1 | No | Yes |
| 17054265 | STATIN-ENCAPSULATED NANOPARTICLE PREPARATION, DENTAL PULP-DERIVED STEM CELLS CONTAINING SAME, AND CELL PREPARATION CONTAINING SUCH STEM CELLS | November 2020 | October 2024 | Abandon | 47 | 4 | 0 | No | Yes |
| 17086859 | MINERAL BASED COMPOSITIONS AND USE THEREOF | November 2020 | July 2023 | Allow | 33 | 1 | 1 | Yes | No |
| 17035682 | HERBAL COMPOSITION FOR GERMINATING HAIR, REJUVENATING HAIR VOLUME AND MANUFACTURING METHOD THEREOF | September 2020 | April 2023 | Abandon | 31 | 2 | 1 | No | No |
| 17024911 | SKIN BRIGHTENING COMPOSITION | September 2020 | September 2021 | Allow | 11 | 1 | 1 | Yes | No |
| 17024761 | DECORATING POWDER COMPOSITION | September 2020 | January 2023 | Allow | 28 | 2 | 1 | Yes | No |
| 16757055 | FRAGRANCE COMPOSITION FOR MASKING OR DEODORIZING MAL-ODOR | September 2020 | May 2025 | Abandon | 60 | 3 | 1 | Yes | No |
| 16981788 | TOPICAL COMPOSITION | September 2020 | November 2023 | Allow | 38 | 2 | 1 | No | Yes |
| 17020567 | OIL-BASED WOUND CARE COMPOSITIONS AND METHODS | September 2020 | December 2024 | Allow | 51 | 3 | 1 | No | No |
| 15733560 | ELONGATE SCAFFOLD COMPRISING INNER AND OUTER PORTION | August 2020 | April 2024 | Abandon | 44 | 0 | 1 | No | No |
| 17003558 | HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE | August 2020 | May 2025 | Abandon | 56 | 5 | 1 | No | Yes |
| 17002941 | PORE HIDING COSMETIC COMPOSITION COMPRISING A PLATE TYPE FILLER, A SILICON ELASTOMER AND AN OIL ABSORBING FILLER | August 2020 | July 2023 | Allow | 34 | 3 | 0 | No | Yes |
| 16971358 | CELL ADHESIVE MATERIAL | August 2020 | June 2024 | Allow | 46 | 1 | 1 | No | No |
| 16996593 | COMPOSITION FOR REMOVING ALDEHYDE-BASED ODORS AND REACTIVE OXYGEN SPECIES | August 2020 | January 2024 | Abandon | 41 | 3 | 1 | No | No |
| 16985902 | CONDITIONER COMPOSITION COMPRISING A CHELANT | August 2020 | February 2021 | Allow | 6 | 2 | 0 | No | No |
| 16931880 | HAIR CARE COMPOSITIONS FOR CALCIUM CHELATION | July 2020 | March 2022 | Allow | 20 | 4 | 0 | No | No |
| 16926069 | SOLID COSMETIC DETERGENTS (TWO-COMPONENT COMPOSITION) | July 2020 | August 2024 | Abandon | 49 | 4 | 1 | No | No |
| 16917966 | ORGANIC AND MINERAL FILTER HYBRID SUNSCREEN | July 2020 | April 2025 | Abandon | 58 | 5 | 0 | No | Yes |
| 16917846 | PETROLATUM-BASED DELIVERY SYSTEMS AND FOR ACTIVE INGREDIENTS | June 2020 | December 2020 | Allow | 5 | 1 | 0 | No | No |
| 16913379 | COSMETIC COMPOSITIONS COMPRISING BIODEGRADABLE POLYMERS | June 2020 | April 2024 | Abandon | 46 | 4 | 1 | No | No |
| 16911013 | Anti-Aging Formula | June 2020 | May 2023 | Abandon | 35 | 1 | 1 | No | No |
| 16910449 | NON-IRRITATING, NON-BLURRING, PHOTOSTABLE OPHTHALMIC SUNSCREEN COMPOSITION | June 2020 | February 2023 | Allow | 32 | 2 | 0 | No | No |
| 16905988 | FRAGRANCE-ENHANCING COMPOSITIONS | June 2020 | November 2023 | Allow | 41 | 3 | 1 | Yes | No |
| 16903439 | CYCLIC HYDRAZIDES AS FRAGRANCE PRECURSOR COMPOUNDS | June 2020 | January 2024 | Abandon | 43 | 2 | 1 | No | No |
| 16899156 | COSMETIC SHEET AND METHOD FOR PRODUCING THE SAME | June 2020 | September 2024 | Abandon | 51 | 4 | 1 | Yes | No |
| 16899219 | NANOEMULSION SYSTEM FOR TRANSDERMAL DELIVERY OF PHARMACEUTICAL COMPOSITIONS AND OTHER ACTIVE AGENTS | June 2020 | March 2023 | Abandon | 33 | 1 | 1 | No | No |
| 16888118 | CRYOGENIC NATURAL SKIN CARE COMPOSITIONS AND CORRESPONDING METHODS | May 2020 | August 2022 | Allow | 27 | 1 | 1 | Yes | No |
| 16883488 | ANTIAGING MICROMOLECULAR METHOD | May 2020 | March 2023 | Abandon | 33 | 2 | 1 | No | No |
| 16881570 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | May 2020 | October 2020 | Allow | 5 | 1 | 1 | No | No |
| 16879639 | HEMP-BASED COSMECEUTICAL COMPOSITIONS AND METHODS OF MAKING SAME | May 2020 | September 2024 | Allow | 52 | 3 | 1 | No | No |
| 16763579 | COSMETIC COMPOSITION FOR BLURRING SURFACE IMPERFECTIONS OF SKIN | May 2020 | May 2024 | Abandon | 48 | 4 | 1 | No | No |
| 16872178 | PETROLATUM-BASED COMPOSITIONS COMPRISING CATIONIC BIOCIDES | May 2020 | October 2020 | Allow | 5 | 1 | 1 | Yes | No |
| 16762046 | HAIR CARE COMPOSITION | May 2020 | January 2023 | Allow | 33 | 2 | 1 | Yes | No |
| 16862694 | Nanopore Delivery Device | April 2020 | February 2022 | Abandon | 22 | 1 | 1 | No | No |
| 16862059 | DETERGENT COMPOSITIONS | April 2020 | September 2024 | Allow | 52 | 5 | 1 | Yes | No |
| 16859208 | Multi-Chrome Cosmetic Hair Composition | April 2020 | June 2022 | Allow | 26 | 1 | 1 | No | No |
| 16854944 | TOPICAL DELIVERY SYSTEM CONTAINING CELLULOSE NANOFIBERS | April 2020 | November 2022 | Abandon | 30 | 2 | 1 | No | No |
| 16846379 | NATURAL HAIR CONDITIONING COMPOSITION | April 2020 | February 2022 | Abandon | 22 | 2 | 0 | No | No |
| 16845748 | NON-IRRITATING, NON-BLURRING OPHTHALMIC SUNSCREEN | April 2020 | April 2022 | Allow | 24 | 2 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WRIGHT, SARAH C.
With a 41.9% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 23.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner WRIGHT, SARAH C works in Art Unit 1619 and has examined 554 patent applications in our dataset. With an allowance rate of 39.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.
Examiner WRIGHT, SARAH C's allowance rate of 39.7% places them in the 4% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by WRIGHT, SARAH C receive 2.82 office actions before reaching final disposition. This places the examiner in the 92% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by WRIGHT, SARAH C is 36 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +51.2% benefit to allowance rate for applications examined by WRIGHT, SARAH C. This interview benefit is in the 95% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 15.4% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 20.0% of cases where such amendments are filed. This entry rate is in the 16% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 82.8% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 63% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 61.3% of appeals filed. This is in the 33% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 72.1% are granted (fully or in part). This grant rate is in the 88% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.2% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 1% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.